Alpha Teknova (NASDAQ:TKNO) Shares Gap Up – Should You Buy?

Alpha Teknova, Inc. (NASDAQ:TKNO)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $9.18, but opened at $9.59. Alpha Teknova shares last traded at $9.67, with a volume of 60,236 shares.

Alpha Teknova Trading Up 2.8 %

The company has a debt-to-equity ratio of 0.12, a current ratio of 4.73 and a quick ratio of 3.94. The business’s 50 day moving average price is $8.06 and its 200-day moving average price is $5.99. The firm has a market capitalization of $502.98 million, a price-to-earnings ratio of -12.79 and a beta of 0.34.

Alpha Teknova (NASDAQ:TKNO) last released its earnings results on Thursday, November 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.04). Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The business had revenue of $9.58 million for the quarter, compared to analyst estimates of $9.30 million. During the same quarter in the previous year, the firm posted ($0.34) EPS. Equities analysts forecast that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of TKNO. China Universal Asset Management Co. Ltd. acquired a new position in shares of Alpha Teknova during the 4th quarter worth $94,000. Whalen Wealth Management Inc. acquired a new stake in shares of Alpha Teknova in the 4th quarter worth approximately $240,000. State Street Corp grew its holdings in shares of Alpha Teknova by 249.3% in the 3rd quarter. State Street Corp now owns 76,645 shares of the company’s stock worth $371,000 after acquiring an additional 54,700 shares during the period. Geode Capital Management LLC grew its holdings in shares of Alpha Teknova by 24.4% in the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock worth $911,000 after acquiring an additional 36,914 shares during the period. Finally, Point72 Asset Management L.P. acquired a new stake in shares of Alpha Teknova in the 3rd quarter worth approximately $1,483,000. Institutional investors and hedge funds own 13.81% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.